ALZHEIMER'S ASSOCIATION LAUNCHES "PROTECT-COG" STUDY TO TEST U.S. POINTER LIFESTYLE AND GLP-1 OR SIMILAR DRUG TO CUT RISK OF COGNITIVE DECLINE
LONDON, July 13, 2026 /PRNewswire/ -- The Alzheimer's Association today announced the launch of the PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy), a first-of-its-kind global clinical trial designed to evaluate whether combining a proven multidomain...
LONDON, July 13, 2026 /PRNewswire/ -- The Alzheimer's Association today announced the launch of the PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy), a first-of-its-kind global clinical trial designed to evaluate whether combining a proven multidomain...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.